Please login to the form below

Not currently logged in
Email:
Password:

alteplase

This page shows the latest alteplase news and features for those working in and with pharma, biotech and healthcare.

AZ says Brilinta hits the mark in new stroke trial

AZ says Brilinta hits the mark in new stroke trial

The currently only approved drug for the treatment of ischaemic stroke is Genentech’s tissue plasminogen activator (tPA) Activase (alteplase) – although this is a controversial therapy as it has an extremely

Latest news

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....